| DB ID | MyCo_2156 |
| Title | Elevation of serum KL-6 levels in patients with hematological malignancies associated with cytomegalovirus or Pneumocystis carinii pneumonia |
| Year | 2002 |
| PMID | 12186700 |
| Fungal Diseases involved | Pneumocystis carinii pneumonia |
| Associated Medical Condition | Hematological Malignancies |
| Genus | Pneumocystis |
| Species | carinii |
| Organism | Pneumocystis carinii |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | KL-6 |
| Biomarker Full Name | KL-6 |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | The clinical samples for this study consisted of three patients with non-Hodgkin’s lymphoma and two with adult T-cell leukemia, all of whom were associated with interstitial pneumonitis by P. carinii or CMV. The samples of the patients without complication of interstitial pneumonitis (Non-IP patients) were obtained from five patients with various hemato- logical malignancies or AIDS. |
| Cohort No. | 5 Patients and 5 control |
| Age Group | 47-81 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | ELISA Based |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | ELISA |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
